All Type of News
New drug-pricing reform will become industry killer
The Ministry for Health and Welfare says that if doctors choose to get a discount on drugs rather than receive the rebates, the government will provide them with incentives in terms of pricing from this October.
Th...
Drugmakers likely to provide less financial aid to local academic conferences
60 pharmaceutical firms and medical instrument makers sponsored the autumn academic congress organized by the Korean Society of Cadiology, it was learned on October 7.
However, observers said that the organizers of...
Concerns growing over use of more potent antibiotics
A health scare is growing here after Japan confirmed last month its first case of a “super bacterium” that is resistant to nearly all known antibiotics.
The news came as a surprise after the more common drug-resis...
Green Cross to conduct phase 1 trial for MGAH22 in HER2-positive carcinoma
Green Cross Corp. says it will conduct phase 1 study for MGAH22 (trastuzumab) after approval of the Korea Food and Drug Administration on October 8.
Developed by the U.S. based MacroGenics Inc., MGAH22 is a next-ge...
More pharmaceutical employees to face layoff
The new drug-pricing reform will hit the job market for those involved in the local pharmaceutical and wholesaling camps, leading to high job instability.
Under the cash reward plan for doctors and pharmacists, so...
Government urged to strengthen ADR monitoring system
A total of 26,827 cases of side-effects caused by the use of drugs to the Korea Food and Drug Administration (KFDA) were reported last year, a 181-fold increase over 2002 (148 cases), according to Rep. Lee Hae-bong of...
R&D-oriented pharmaceutical firms to benefit from exemption of drug price cut
The drug price cut will be significantly exempted for drugmakers who intend to spend more money on the research and development (R&D) of new drugs, according to the Ministry of Health and Welfare.
Pharmaceutical ma...
Pharmaceutical firms sweating over 2011 plan
Many Korean pharmaceutical companies are struggling to finalize their business plans for the new year, an industry survey found recently.
A new drug-pricing reform has led many companies to say they have no plans ...
Korea United to export aceclofenac to Middle East and North Africa
The Korea United Pharmaceutical Ind. said on October 6 it has signed a contract with ITROM Co. to export its Clanza (aceclofenac) CR tablets worth $2.4 million as the first shipment to countries in Middle East and Nor...
Government to strengthen trademark protection in China
The government aims to protect the intellectual property right (IPR) of Korean companies in China, amid growing trademark disputes.
In a 2010 Korea-China IPR protection strategy forum to be held on October 21, the ...
